Drug Markets/Febuxostat

Febuxostat

29 NDCs across 14 manufacturers|27 Generic,2 Brand

Febuxostat is used to treat gout, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Feb 13, 2009, and the first generic was approved Jul 1, 2019. FDA's Orange Book lists 26 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $41 million on Febuxostat across 341,000 claims for 84,000 beneficiaries.

Febuxostat is available as 29 NDCs from 14 manufacturers (27 generic, 2 brand), with NADAC prices from $0.19 to $10.55 per EA — the most expensive product costs about 55× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

29

27G / 2B

Manufacturers

14

competing in market

Price Spread

$0.19 – $10.55

per EA

7d Activity

23↑6 flat

avg +2.6% WoW · of 29 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

29 NDCs total, 29 shown

WatchDrug ↕Price 7d Change ↕
ULORIC 80 MG TABLET
$10.5531
per EA
—
ULORIC 40 MG TABLET
$10.5345
per EA
—
FEBUXOSTAT 80 MG TABLET
$0.6464
per EA
—
FEBUXOSTAT 40 MG TABLET
$0.5353
per EA
—
FEBUXOSTAT 80 MG TABLET
$0.2810
per EA
—
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 80 MG TABLET
$0.2570
per EA
+2.73%
FEBUXOSTAT 40 MG TABLET
$0.2116
per EA
—
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%
FEBUXOSTAT 40 MG TABLET
$0.1923
per EA
+2.53%

Frequently Asked Questions

What is Febuxostat used to treat?

Febuxostat is used to treat gout, per the National Library of Medicine's MED-RT classification.

When did Febuxostat become available as a generic?

FDA approved the first generic Febuxostat (ANDA) on Jul 1, 2019. The Orange Book currently lists 26 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Febuxostat?

In 2024, Medicare Part D spent $41 million on Febuxostat across 341,000 claims for 84,000 beneficiaries.

How many Febuxostat products are on the market?

The Febuxostat drug market contains 29 NDCs from 14 manufacturers — 27 generic and 2 brand products.

What is the price range for Febuxostat?

NADAC reference prices for Febuxostat range from $0.1923 to $10.5531 per EA — the most expensive product costs about 55× the cheapest.

Is generic Febuxostat cheaper than brand?

The average generic NADAC for Febuxostat is $0.2522 per EA, versus $10.5438 for brand-labeled products — brand versions average about 42× the generic price.

Which manufacturers make Febuxostat?

14 manufacturers list Febuxostat in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (4), Takeda Pharmaceuticals America, Inc. (2), Dr. Reddy's Laboratories Inc. (2), Viona Pharmaceuticals Inc. (2), Hikma Pharmaceuticals USA Inc. (2).

How has the price of Febuxostat changed recently?

Over the past 7 days, 23 Febuxostat NDCs rose and 0 fell, with a market-wide average change of +2.6%.